. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisDrug Industry/economicsHumansNeoplasms/economicsPatients
Year: 2013 PMID: 23752409 DOI: 10.1038/nbt.2615
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908